Stock Groups

Factbox-GSK’s consumer health business -Breaking

© Reuters. FILEPHOTO: This is the GlaxoSmithKline building in Hounslow west London, Britain on June 18, 2013. REUTERS/Luke MacGregor

(Reuters) – Unilever (NYSE 🙂 approached GlaxoSmithKline NYSE : about purchasing the consumer goods division of the pharmaceutical company. This was after a paper reported that a $50 billion ($68.4 Billion) offer it had made to buy GlaxoSmithKline had been rejected.

GSK did not comment on this alternative to the plan to list the business on its own on the London Stock Exchange.


Which U.S. pharmacy company owns the consumer goods industry? Pfizer The 32% share of (NYSE:) includes brands such Asprin, Sensodyne, Parodontax, Voltaren and Panadol as well pain-relief medications Advil, Voltaren & Panadol, Otrivin nasal Spray, Cold and Flu Medicine Theraflu and Centrum Vitamins.

GSK and Pfizer combined their consumer health business in 2019 in an agreement.

GSK, which had previously reached a $13billion deal to acquire full control over a consumer venture in health with Novartis (Swiss drug group Novartis), had made the purchase.


GSK is a leading OTC (over-the-counter) health company with the number 1 position in many markets, including Germany and the United States.

Its rivals include Johnson & Johnson (NYSE:), Bayer (OTC:) and Sanofi (NASDAQ:).


It generated 10 billion pounds in sales ($13.7billion) for 2020.

GSK’s two main divisions were pharmaceuticals and vaccines. The company had a turnover of 34 Billion pounds in that same year.


Dave Lewis, the former chief executive officer of British supermarket company Tesco (OTC): has been named to lead the operation when it’s spun off.

Brian McNamara is the new chief executive. He has held this position since 2016 as part of GSK.

A new headquarters will be built at Weybridge, southern England by the demerged firm.

($1 = 0.7314 pounds)

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.